Manufacturer Novo Nordisk says a daily tablet of the drug could be more convenient for some people than weekly injections.
The therapy works by genetically modifying cells to enable the body’s own immune system to recognise and attack problem cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results